Drug profile · INN
bempedoic acid
NILEMDO
- US status
- approved
- Patents linked
- 8
- News articles
- 0
Quick answer
bempedoic acid (NILEMDO) is an FDA-listed pharmaceutical active ingredient. Associated with Esperion Therapeutics. Route of administration: oral. Current US regulatory status: approved.
Key facts
Related patents
Search patents →-
US 12404227
Methods of making bempedoic acid and compositions of the same
granted -
US 12398087
Methods of making bempedoic acid and compositions of the same
granted -
US 12344578
Salt forms of bempedoic acid and methods for using the same
granted -
US 11987548
Methods of making bempedoic acid and compositions of the same
granted -
US 11926584
Methods of making bempedoic acid and compositions of the same
granted -
US 11760714
Methods of making bempedoic acid and compositions of the same
granted -
US 11613511
Methods of making bempedoic acid and compositions of the same
granted -
US 11407705
Methods of making bempedoic acid and compositions of the same
granted
Frequently asked questions
What is bempedoic acid?
bempedoic acid (NILEMDO) is an FDA-listed pharmaceutical active ingredient. Associated with Esperion Therapeutics. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for bempedoic acid?
NILEMDO is a marketed brand name for bempedoic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bempedoic acid?
bempedoic acid has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.